scholarly journals A coordinated national UK liver transplant program response, prioritising waitlist recipients with the highest need, provided excellent outcomes during the first wave of the COVID‐19 pandemic

2021 ◽  
Author(s):  
Steven Masson ◽  
Rhiannon Taylor ◽  
Julie Whitney ◽  
Anya Adair ◽  
Magdy Attia ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Transplant Program

scholarly journals HIV and Liver transplantation: The British Columbia Experience, 2004 to 2013

2014 ◽  
Vol 25 (3) ◽  
pp. 159-162 ◽  
Author(s):  
Clara Tan-Tam ◽  
Pamela Liao ◽  
Julio S Montaner ◽  
Mark W Hull ◽  
Charles H Scudamore ◽  
...  
Keyword(s):  
British Columbia ◽  
Liver Transplantation ◽  
Hepatitis C Virus ◽  
Liver Disease ◽  
Hepatitis C ◽  
Liver Transplant ◽  
Clinical Outcomes ◽  
Disease Status ◽  
Transplant Program ◽  
End Stage

BACKGROUND: The demand for definitive management of end-stage organ disease in HIV-infected Canadians is growing. Until recently, despite international evidence of good clinical outcomes, HIV-infected Canadians with end-stage liver disease were ineligible for transplantation, except in British Columbia (BC), where the liver transplant program of BC Transplant has accepted these patients for referral, assessment, listing and provision of liver allograft. There is a need to evaluate the experience in BC to determine the issues surrounding liver transplantation in HIV-infected patients.METHODS: The present study was a chart review of 28 HIV-infected patients who were referred to BC Transplant for liver transplantation between 2004 and 2013. Data regarding HIV and liver disease status, initial transplant assessment and clinical outcomes were collected.RESULTS: Most patients were BC residents and were assessed by the multidisciplinary team at the BC clinic. The majority had undetectable HIV viral loads, were receiving antiretroviral treatments and were infected with hepatitis C virus (n=16). The most common comorbidities were anxiety and mood disorders (n=4), and hemophilia (n=4). Of the patients eligible for transplantation, four were transplanted for autoimmune hepatitis (5.67 years post-transplant), nonalcoholic steatohepatitis (2.33 years), hepatitis C virus (2.25 years) and hepatitis B-delta virus coinfection (recent transplant). One patient died from acute renal failure while waiting for transplantation. Ten patients died during preassessment and 10 were unsuitable transplant candidates. The most common reason for unsuitability was stable disease not requiring transplantation (n=4).CONCLUSIONS: To date, interdisciplinary care and careful selection of patients have resulted in successful outcomes including the longest living HIV-infected post-liver transplant recipient in Canada.

Experience of a Successful Pediatric Liver Transplant Program in Mexico

2005 ◽  
Vol 37 (2) ◽  
pp. 1201-1202 ◽  
Author(s):  
G. Varela-Fascinetto ◽  
R. Dávila-Pérez ◽  
J. Nieto-Zermeño ◽  
E. Bracho-Blanchet ◽  
V. Fuentes-Garcı́a ◽  
...  
Keyword(s):  
Liver Transplant ◽  
Transplant Program ◽  
Pediatric Liver ◽  
Pediatric Liver Transplant

The Patient Coordinator in a Liver Transplant Program

1988 ◽  
Vol 17 (1) ◽  
pp. 195-206
Author(s):  
Alma E. Heyl ◽  
Sandra Staschak ◽  
Pat Folk ◽  
Vicki Fioravanti
Keyword(s):  
Liver Transplant ◽  
Transplant Program

scholarly journals Acute Liver Failure due to Wilson Disease: Eight Years of the National Liver Transplant Program in Uruguay

2019 ◽  
Vol 18 (1) ◽  
pp. 187-192 ◽  
Author(s):  
Victoria Mainardi ◽  
Karina Rando ◽  
Marcelo Valverde ◽  
Daniela Olivari ◽  
Jorge Castelli ◽  
...  
Keyword(s):  
Liver Failure ◽  
Liver Transplant ◽  
Acute Liver Failure ◽  
Wilson Disease ◽  
Transplant Program

Starting a Liver Transplant Program

1989 ◽  
Vol 9 (03) ◽  
pp. 159-167 ◽  
Author(s):  
Byers Shaw
Keyword(s):  
Liver Transplant ◽  
Transplant Program

Clinical chemistry and post-liver-transplant monitoring

1997 ◽  
Vol 43 (8) ◽  
pp. 1546-1554 ◽  
Author(s):  
Peter E Hickman ◽  
Julia M Potter ◽  
Amadeo J Pesce
Keyword(s):  
Liver Transplant ◽  
Clinical Chemistry ◽  
Biliary Tree ◽  
Diagnostic Value ◽  
Therapeutic Drug ◽  
Early Presentation ◽  
Transplant Program ◽  
Real Value ◽  
End Stage ◽  
Clinical Problems

Abstract Liver transplantation is an accepted therapy for end-stage liver disease. After allografting, a variety of clinical problems may require laboratory involvement for accurate and timely diagnosis and intervention. Critical factors in the choice of a laboratory test menu to support a transplant program include turnaround times that support clinical decisionmaking, real diagnostic value, and real value for money. Particular clinical problems, whose early presentation must be anticipated, include graft ischemia, primary nonfunction, and hepatic artery thrombosis. Acute rejection is common at 5–10 days posttransplantation, the principal target being the biliary tree. Longer-term problems are associated with the therapeutic drug measurement of cyclosporin A and, increasingly, tacrolimus (FK506); the side effects of immunosuppressant therapy also require monitoring. A successful liver transplant program can be adequately supported with a simple battery of automated tests that are cheap, fast, and available at all times.

scholarly journals Self‐limited HBV infection of the recipient does not reactivate after liver transplantation: Observations from a 30‐year liver transplant program

2020 ◽  
Author(s):  
R.R. Ossami Saidy ◽  
Muenevver Demir ◽  
Pauline Nibbe ◽  
Eva‐Maria Dobrindt ◽  
Robert Oellinger ◽  
...  
Keyword(s):  
Liver Transplantation ◽  
Liver Transplant ◽  
Hbv Infection ◽  
Transplant Program

Mortality following liver resection in U.S. medicare patients?Does the presence of a liver transplant program affect outcome?

2005 ◽  
Vol 9 (4) ◽  
pp. 552-552
Author(s):  
E DIXON ◽  
S SCHNEEWEISS ◽  
J PASIEKA ◽  
O BATHE ◽  
F SUTHERLAND ◽  
...  
Keyword(s):  
Liver Resection ◽  
Liver Transplant ◽  
Transplant Program ◽  
Medicare Patients
Sign in / Sign up

Export Citation Format

Share Document